Clinical Advisor featured a study by Dr Chidozie U. Nduka that has found that antiretroviral therapy (ART) may be the single most consistent determinant of diabetes in patients with HIV.

Heller S, Amiel S, Campbell, M, Choudhary P, Cooper C, Dimairo M, Elliott J, Hammond P, Lee E, Lindsay R, Mansell P, Waugh N, White D. Relative effectivenes s of ins ulin pump treatment over multiple daily injections and s tructured education during flexible intens ive ins ulin treatment for type 1 diabetes : clus ter randomis ed trial (REPOSE). BMJ 2017;356:j1285 doi: 10.1136/bmj.j1285. http://www.bmj.com/content/356/bmj.j1285

Chalmers J R, Wojnarowska F, Kirtschig G, Mason J, Childs M, Whitham D, Harman K, Chapman A, Walton S, Schmidt E, Godec T R, Nunn A J & Williams H C. A randomised controlled trial to compare the safety, effectiveness and cost effectiveness of doxycycline (200 mg/day) with oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. Health Technology Assessment Volume: 21, Issue:10, Published in March 2017. https://dx.doi.org/10.3310/hta21100

This week Warwick Evidence is welcoming their latest addition to the team, Theo Mantopoulos. We are excited about working together and getting to know each other!